Abstract
Shikonin, a natural plant product isolated from the herb Lithospermum erythrorhizon, has been found to strongly stimulate immunogenic cell death (ICD) of tumor cells, which induced a potent immune response by dendritic cells (DCs) to suppress tumor growth and/or metastasis. Recently, specific intracellular protein targets including heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and pyruvate kinase-M2 (PKM2) have been demonstrated to act as candidate receptors for shikonin. Among them, direct binding-interference with hnRNPA1 was found to be critical for shikonin-induced immunogenicity of mammary tumor cells, which can result in strong suppression of tumor metastasis. Mechanistic studies have further revealed that specific damage-associated molecular patterns (DAMPs) associated with immunogenicity, including heat shock proteins 70 (HSP-70), calreticulin (CRT) and high mobility group box 1 (HMGB1) in tumor cell lysate (TCL), can play important and comprehensive roles in activating specific immunities of tumor cell lysate (TCL)-pulsed DCs. In this brief review article, we present these findings together and further provide a molecular mode of action as the pharmacological basis of SK-induced ICD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
